Literature DB >> 3752062

The exposure odds ratio in nested case-control studies with competing risks.

W D Flanders, W C Louv.   

Abstract

A nested case-control study, also known as an ambidirectional study, is a case-control study within a cohort study. Although distortion by competing risks is well-recognized in follow-up studies, the problem has not been as widely appreciated in nested case-control studies. This paper extends previous work concerning the bias associated with competing risks for nested case-control studies. Specifically, the distorting effect of competing risks is illustrated for three methods of control selection. Assuming the proportional hazards model, the authors derived formulas for the bias of the odds ratio when competing risks cannot be ignored. Examples illustrate the magnitude of bias that occurs when the exposure of interest is associated with competing causes of death or withdrawal.

Entities:  

Mesh:

Year:  1986        PMID: 3752062     DOI: 10.1093/oxfordjournals.aje.a114442

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  Medical disorders among inpatients with autism in Denmark according to ICD-8: a nationwide register-based study.

Authors:  Marlene B Lauritsen; Ole Mors; Preben B Mortensen; Henrik Ewald
Journal:  J Autism Dev Disord       Date:  2002-04

2.  An epidemiologic investigation of potential risk factors for suicide attempts.

Authors:  K R Petronis; J F Samuels; E K Moscicki; J C Anthony
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1990-07       Impact factor: 4.328

3.  Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide.

Authors:  H Schelleman; W B Bilker; C M Brensinger; F Wan; S Hennessy
Journal:  Clin Pharmacol Ther       Date:  2010-06-30       Impact factor: 6.875

4.  Trans fatty acid and coronary disease: the debate continues. 1. The use of population attributable risk.

Authors:  A Leviton
Journal:  Am J Public Health       Date:  1995-03       Impact factor: 9.308

5.  Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression.

Authors:  Satabdi Chatterjee; Vishal Bali; Ryan M Carnahan; Hua Chen; Michael L Johnson; Rajender R Aparasu
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 3.923

6.  Cisapride and ventricular arrhythmia.

Authors:  Sean Hennessy; Charles E Leonard; Craig Newcomb; Stephen E Kimmel; Warren B Bilker
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

7.  Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers might be associated with lung adenocarcinoma risk: a nationwide population-based nested case-control study.

Authors:  Han-Lin Hsu; Chih-Hsin Lee; Chien-Hsin Chen; Jun-Fu Zhan; Szu-Yuan Wu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

8.  Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding.

Authors:  H Schelleman; W B Bilker; C M Brensinger; X Han; S E Kimmel; S Hennessy
Journal:  Clin Pharmacol Ther       Date:  2008-08-06       Impact factor: 6.875

9.  Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures.

Authors:  Sean Hennessy; Warren B Bilker; Charles E Leonard; Jesse Chittams; Cristin M Palumbo; Jason H Karlawish; Yu-Xiao Yang; Ebbing Lautenbach; William B Baine; Joshua P Metlay
Journal:  J Clin Epidemiol       Date:  2007-05-10       Impact factor: 6.437

10.  Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk.

Authors:  Hedi Schelleman; Warren B Bilker; Colleen M Brensinger; Fei Wan; Yu-Xiao Yang; Sean Hennessy
Journal:  Am J Med       Date:  2010-02       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.